BioCryst wins FDA OK for ORLADEYO oral pellets in HAE kids
BioCryst (NASDAQ:BCRX) announced FDA approval (Dec 12, 2025) of ORLADEYO oral pellets (berotralstat)…
Browsing Tag
hereditary angioedema
1 post